Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

by | PRNewswire Asia

HONG KONG, Jan. 14, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy...

COSRX Kicks Off 2026 with "NEW YEAR, NEW BRIGHT" Alpha-Arbutin Moving Car Pop-Up in Kuala Lumpur

by | PRNewswire Asia

KUALA LUMPUR, Malaysia, Jan. 14, 2026 /PRNewswire/ — Global No.1* friendly derma brand COSRX is bringing its most viral brightening with the Alpha-Arbutin Pop-Up, a high-energy, interactive skincare experience designed to turn everyday city moments into...

Ricoh Named to CDP's Double A List for the Third Consecutive Year

by | PRNewswire Asia

Recognised as a leader in corporate transparency and action on climate change and water security TOKYO, Jan. 14, 2026 /PRNewswire/ — Ricoh’s global leadership in corporate transparency and performance on climate change and water security disclosure have...

Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference

by | PRNewswire Asia

Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to scale U.S. manufacturing and R&D capabilities, strengthening its global supply chain, production and operations INCHEON,...

Teoxane to Launch First APAC Regional Academy in Bangkok

by | PRNewswire Asia

New hub strengthens Teoxane’s commitment to scientific education and clinical partnerships across Asia-Pacific GENEVA, Jan. 14, 2026 /PRNewswire/ — Teoxane opens its first APAC Regional Academy in Bangkok, Thailand this January, expanding its global...

DNV SUPPORTS NOUL IN IVDR CERTIFICATION FOR AI-BASED MEDICAL DIAGNOSTIC PRODUCTS

by | PRNewswire Asia

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ — DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer diagnostics company Noul to certify their malaria diagnosis, blood cell morphology and...